MODERATE TO SEVERE OPIOID-USE DISORDER
Clinical trials for MODERATE TO SEVERE OPIOID-USE DISORDER explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE OPIOID-USE DISORDER trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE OPIOID-USE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Monthly shot study tests better dosing for opioid addiction
Disease control CompletedThis study tested two different doses (100 mg vs 300 mg) of a monthly buprenorphine shot in 785 adults with moderate to severe opioid use disorder. The goal was to see which dose helped people stay in treatment and reduce opioid use. Results showed how well each dose worked for m…
Matched conditions: MODERATE TO SEVERE OPIOID-USE DISORDER
Phase: PHASE4 • Sponsor: Indivior Inc. • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
New shot shows promise for opioid addiction management
Disease control CompletedThis study looked at how a new injectable medication, INDV-6001, works in the body and whether it is safe for adults with moderate to severe opioid use disorder. 123 participants received multiple doses, and researchers checked drug levels and side effects. The goal was to find t…
Matched conditions: MODERATE TO SEVERE OPIOID-USE DISORDER
Phase: PHASE2 • Sponsor: Indivior Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC